YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | SC 13G/A:超过5%持股股东披露文件(修正)-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%)等
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | SC 13G:超过5%持股股东披露文件-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%)等
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | SC 13D:超过5%持股股东披露文件-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)
暂无数据